Bibliographic Citation
| - Kodjikian Laurent, Souied Eric H., Mimoun Gerard, Mauget-Faysse Martine, Behar-Cohen Francine, Decullier Evelyne, Huot Laure, Aulagner Gilles, Grp GEFAL Study. Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial. Ophthalmology: Journal of The American Academy of Ophthalmology, Elsevier, 2013, 120 (11), pp.2300-2309. ⟨10.1016/j.ophtha.2013.06.020⟩
- Kodjikian Laurent, Souied Eric H., Mimoun Gerard, Mauget-Faysse Martine, Behar-Cohen Francine, Decullier Evelyne, Huot Laure, Aulagner Gilles. Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial. Ophthalmology: Journal of The American Academy of Ophthalmology, Elsevier, 2013, 120 (11), pp.2300-2309. ⟨10.1016/j.ophtha.2013.06.020⟩
- Kodjikian Laurent, Souied Eric H., Mimoun Gerard, Mauget-Faysse Martine, Behar-Cohen Francine, Decullier Evelyne, Huot Laure, Aulagner Gilles . Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial . Ophthalmology: Journal of The American Academy of Ophthalmology, 2013, 120 (11), pp.2300-2309 . ⟨10.1016/j.ophtha.2013.06.020⟩
|